Mucosal modulation of immune responses to heat shock proteins in autoimmune arthritis

Biotherapy

Volumn 10, Issue 3, 1998, Pages 213-221

  Bonnin, Dustan ^a,b,c   Albani, Salvatore ^a,b,c  

^a Departments of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c Cevis Corporation   (United States)

Author keywords

Autoimmunity; dnaJ; Heat shock proteins; Immunomodulation; Oral tolerance; Rheumatoid arthritis; Th1 Th2

Indexed keywords

COLLAGEN TYPE 2; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; OM 89;

ADJUVANT ARTHRITIS; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOTHERAPY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0031966941     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02678299     Document Type: Article

References (40)

1. Wells AG. Studies on the chemistry of anaphylaxis (III). Experiments with isolated proteins, especially those of the hen's egg. 1911: J Infect Dis: 8: 147-71.
2. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992; 176: 1355-64.
3. Haque MA, Yoshino S, Inada S, Nomaguchi H, Tokunaga O, Kohashi O. Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDaheat shock protein. Eur J Immunol 1996; 26: 2650-56.
4. Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol 1995; 155: 3653-59.
5. Miller JFAP, Basten A. Mechanisms of tolerance to self. Curr Opin Immunol 1996; 8: 815-21.
6. Feige U, van Eden W. Infection, autoimmunity and autoimmune disease. In: Feige U, Morimoto RI, Yahara I, Polla B, EDS. Stress-Inducible Cellular Responses, Basel: Birkhauser Verlag, 1996: 359-73.
7. Brocke S, Gijbels K, Allegretta M, Ferber I, Piercy C, Blankenstein T, Martin R, Utz U, Krin N, Mitchell D, Veromaa T, Waisman A, Gaur A, Conlon P, Ling N, Gairchild P, Wraith DC, O'Garra A, Fathman CG, Steinman L. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 1996; 379: 343-6.
8. Jones DB, Coulson AFW, Duff GW. Sequence homologies between hsp60 and autoantigens. Immunol Today 1993; 14: 115-8.
9. Albani S, Ravelli A, Massa M, et al. Immune response to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity. J Pediatr 1994; 124: 561-65.
10. Albani S, Keystone EC, Nelson JL, et al. Positive selection in autoimmunity: Abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nature Med 1995; 1: 448-4525.
11. Windhagen A, Nicholson LB, Weiner HL, Kuchroo VK, Hafler DA. Role of Thl and Th2 cells in neurologic disorders. Chem Immunol 1996; 63: 171-86.
12. van Eden W, Thole JER, van der Zee R, et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988; 331: 171-3.
13. van Eden W. Heat-shock proteins as immunogenic bacterial antigens with the potential to induce and regulate autoimmune arthritis. Immunol Rev 1991; 121: 5-28.
14. Bell CHH. Do stress proteins have a regulatory role in autoimmune rheumatoid arthritis? Biochem Soc Trans 1996; 24: 494S.
15. Mayer L, So LP, Yio XY, SmaU G. Antigen trafficking i the intestine. Ann NY Acad Sei 1997; 28-35.
16. Kelsall BL, Strober W. The role of dendritic cells in antigen processing in the Peyer's patch. Ann NY Acad Sei 1997; : 47-54.
17. Staines NA, Harper N, Ward FJ, Mahnstrom V, Holmdahl R, Bansal S. Mucosal tolerance and suppression of collageninduced arthritis (CIA) induced by nasal inhalaion of synthetic peptide 184-198 of bovine type II collagen (CD) expressing a dominant T cell epitope. Clin Exp Immunol 1996; 103: 368-75.
18. Langermann S, Palaszynski S, Sadziene A, Stover CK, Koenig S. Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 1994; 372: 552-5
19. Weiner HL, Friedman A, Miller A, et al. Oral tolerance: Immunologie mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 1994; 12: 809-37.
20. Khoruts A, Jenkins ML. Studying immunological tolerance by physically monitoring antigen-specific T cells in vivo. Ann NY Acad Sei 1997; : 72-9.
21. Nicholson LB, Kuchroo VK. Manipulation of the Thl/Th2 balance in autoimmune disease. Curr Opin Immunol 1996; 8: 837-42
22. Druet P, Sheela R, Pelletier L. Thl and Th2 ceUs in autoimmunity. Chem Immunol 1996; 63:158-70.
23. Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differntially the Thl/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995; 80: 707-18.
24. Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA, Jr., Weiner HL. Oral tolerance in myelin basic protein Tcell receptor transgenic mice: Suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory ceUs. Proc Nati Acad Sei USA 1996; 93: 388-91.
25. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Nad Acad Sei USA 1992; 89: 9784-88.
26. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18: 335-43.
27. Kirn P-H, Kagnoff MF. Transforming growth factor-1 is a costimulator for IgA production. J Immunol 1990; 144: 3411-16.
28. Karpus WJ, Swanborg RH. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-/?. J Immunol 1991 ; 146: 1163-68.
29. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177-80.
30. Windhagen A, Nicholson LB, Weiner HL, Kuchroo VK, Hafler DA. Role of Thl and Th2 cells in neurologic disorders. Chem Immunol 1996; 63: 171-86.
31. Elliott MJ, Maini RN, Feldmann m, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor a. Arthritis Rheum 1993; 36:1681-90.
32. Fincato G, Polentarutti N, Sica A, Mantovani A, Colotta F. Expression of a heat-inducible gene of the HSP70 family in human myelomanocytic cells: Regulation by Bacterial Products and Cytokines. Blood 1991; 77:3: 579-86.
33. Willis D, Moore AR, Gowland G, Willoughby DA. OM-89 modulation of chronic inflammation: relevance to clinical use. Br J Rheumatol 1995; 34: 525-8.
34. Willis D, Moore AR, Gowland G, Willoughby DA. Polyarthritis in the rat: effects of tolerance and sensitization to the bacterial extract OM-89 with a possible mode of action. Br J Rheumatol 1995; 34: 1135-8.
35. Trentham DE, Dynesius-Trentham RA, Orav EJ, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261: 1727-30.
36. Hogervorst EJM, Boog CJP, Wagenaar JPA, Wauben MHM, van der Zee R, van Eden W. T cell reactivity to an epitope of the mycobacterial 65-kDa heat-shock protein (hsp65) corresponds with arthritis susceptibility in rats and is regulated by hsp 65specific cellular responses. Eur J Immunol 1991; 21: 1289-96.
37. La Cava A, Nelson JL, Oilier WER, et al. Genetic bias in immune responses to a cassette shared by different microorganisms in patients with rheumatoid arthritis. J Clin Invest 1997; 100: 658-63.
38. Albani S, Carson DA. A multistep molecular mimicry hypothesis for the pathogenesis of rheumatoid arthritis. Immunol Today 1996; 17: 466-8.
39. Birk OS, Dovek DC, Elias D et al. A role of Hsp60 in autoimmune diabetes: Analysis in a transgenic model. Proceedings of the National Academy of Sciences USA 1996; 93: 1032-37.
40. Van Noort JM, van Sechel AC, Bajramovic JJ et al. The small heat-shock protein a/3-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995; 375: 798-801.